Neuropathy in Medical News

Quigley Corporation Announces Final Results of Quigley Pharma's Phase IIb Study

... formulations. The ADA estimates that neuropathy occurs in up to 60-70% of diabetics, and an ... diagnosis of diabetes and symptoms of peripheral neuropathy were eligible for enrollment into the study. ... ages of 18 and 70 with a diagnosis of diabetic neuropathy were enrolled in the study. Duration ...

Neuropathy Patients, Doctors and Medical Professionals Rally in Sacramento to Demand Access to Lifesaving Medical Treatments

... Congressional Delegation to Remember Needs of neuropathy Patients at 3rd Annual "Neuropathy Action ... for national health care reform, more than 300 neuropathy patients, physicians and medical professionals ... to life-sustaining and lifesaving treatments for neuropathy patients. At a press conference kicking off the ...

Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009

... of Subjects with Moderately Severe Diabetic neuropathy Shows Statistically Significant Improvement in ... to develop SB-509 as a treatment for diabetic neuropathy (DN) at the 69th Annual Scientific Sessions of ... both diabetic microvascular disease and metabolic neuropathy are evident. The statistically significant ...

High Blood Fats Tied to Diabetic Nerve Loss

... Triglycerides better predictor of neuropathy than blood glucose levels, study suggests ... risk of developing a serious complication called neuropathy -- the loss or damage of nerves that results in ... significantly more likely to experience worsening neuropathy over one year. Other factors, including blood ...

First-Time National Poll Confirms Neuropathy Hits Millions in Their Prime

... Data shows 82% of patients have neuropathy onset during their 30s-60s NEW YORK, May 13 /PRNewswire-USNewswire/ -- A new national neuropathy Association poll of peripheral neuropathy patients finds that the majority of respondents ...

SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S.

... patients with G6PD deficiency. Peripheral neuropathy : Peripheral neuropathy (motor loss and muscle weakness) has been ... oral dapsone treatment. No events of peripheral neuropathy were observed in clinical trials with topical ...

Sen. Carolyn Allen Calls for Patient Rights and Treatment Option Awareness

... the Senate Lawn at the Arizona State Capital, the neuropathy Action Foundation (NAF), along with Sen. Allen ... help." Dr. David Saperstein, co-director of neuropathy Association Certified Clinic at Banner Good ... the brochure came from the types of calls to the neuropathy Action Foundation from patients who wonder why ...

The Quigley Corporation Reports First Quarter 2009 Results

... IIb clinical study for QR-333 Diabetic Peripheral neuropathy in November 2008, which reduced R&D ... Company announced that its Diabetic Peripheral neuropathy Phase IIb clinical study demonstrated a ... the potential for the QR-333 drug for Diabetic neuropathy and suggest possible disease modification. ...

Data on VELCADE(R) (Bortezomib) for Injection Based Therapies to be Presented at the International Myeloma Workshop

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral ...

ReBuilder Medical (RBRM) Neuropathy Market Doubles to $5 Billion

... neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs ... non-surgical treatment for diabetic peripheral neuropathy which is non-invasive, has no side effects and ... More information on ReBuilder Medical and its neuropathy products can be found at: ...

Doctors Issue New Neuropathy Test Guidelines

... Neurology . "There are many people with a neuropathy who have been walking around for years without ... and treated. Both neurologists and people with neuropathy need to know that the appropriate choice of tests ... for Health in Aging has more about diabetic neuropathy . -- Robert ...

LSUHSC's England leads development of new testing guidelines for common nerve disorder

... studies recommending new testing guidelines for neuropathy a common degenerative nerve disorder that to ... certain cases. "There are many people with a neuropathy who have been walking around for years without ... of Neurology. "Both neurologists and people with neuropathy need to know that the appropriate choice of tests ...

Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter

... safe treatment for diabetic peripheral neuropathy with little to no side effects. To date there is ... a "first line" treatment for diabetic peripheral neuropathy and possibly could develop a significant ... symptoms of peripheral neuropathy. Diabetic neuropathy is among the most common complications of ...

Foot Problems Common Among People With Diabetes

... neuropathy occurs in 60 to 70% of cases U-M Health Minute: ... says Miller. The swelling was caused by neuropathy -- a result of nerve damage that is common among ... that whole event is delayed in someone who has neuropathy and diabetes," says Holmes. When someone has ...

The Neuropathy Association's Scientific Research Grants Focus: Autoimmune and Chemotherapy-Induced Neuropathies

... NEW YORK, Nov. 10 /PRNewswire-USNewswire/ -- The neuropathy Association has announced two awardees for its ... Research Grants Program. Every year, The neuropathy Association--a national patient-based non-profit ... chosen from eleven applicants involved in neuropathy research at medical institutions across North ...

UT Southwestern launches study of surgical option for treating diabetic and other neuropathies

... in patients with diabetic neuropathy. neuropathy is nerve-related pain, often associated with diabetes. The risk of developing neuropathy increases the longer a person has diabetes, and ... which originate from the spine. "Patients with neuropathy are often told that the problem is irreversible ...

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral ...

The cause of all hereditary sensory and autonomic neuropathy type II cases has been established

... help to explain all the cases of hereditary neuropathy type II. Hereditary sensory and autonomic neuropathy type II (HSANII) is a severe and early onset ... for individuals suffering from hereditary neuropathy type II. In 2004, Dr. Rouleau's team identified ...

The Neuropathy Association Featured on NBC's 'Today Show' as Part of National Neuropathy Week

... -- Tina Tockarshewsky, executive director at The neuropathy Association, today called for heightened public ... interview with Al Roker on the "Today Show." The neuropathy Association is a non-profit organization whose ... week-long activities to observe National neuropathy Week (May 12-16), which underscores the toll this ...

Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy and ...

Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy and ...

Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy and ...

VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy and ...

Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy and ...

Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy and ...

Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives

... factor (VEGF) for the treatment of diabetic neuropathy (DN). Sangamo is building on this positive data ... of VEGF for the treatment of diabetic neuropathy at both the Annual Scientific Sessions of the ... in subjects with mild to moderate diabetic neuropathy over a six-month period after treatment with ...

A pain-free window into painful neuropathies

... of 2.8 in people with neuropathy. Patients with neuropathy also had fewer of the structures at the base of ... they can to prevent further damage. neuropathy is very difficult to treat, and part of the ... damage, said Herrmann, director of the Peripheral neuropathy Service at Strong Memorial Hospital. Treatments ...

FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma

... Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. ... diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy and ...

Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets

... Longer Term Growth of Diabetic neuropathy Market Will Be Driven by Launches of ... Therapies for the painful symptoms of diabetic neuropathy will continue to dominate sales, and few patients ... of the 2006-2016 forecast period. "The diabetic neuropathy market will experience growth during the second ...

Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer

... date. In contrast, data from the published literature report evidence of neuropathy in 30 percent of patients, including severe neuropathy (Grade 3/4) in almost 2 percent of patients.i Neutropenia was the ...

The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts

... POSITIVE FINDING FOR QR-333 COMPOUND TO TREAT DIABETIC PERIPHERAL neuropathy EXPANDS POTENTIAL Diabetic Peripheral neuropathy is a common complication of diabetes associated with nerve damage in the ...

Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification

... applied topically to the feet of subjects suffering from painful diabetic neuropathy and over the course of 12 weeks, it significantly improved both maximal ... outlook for this investigational new drug. The Diabetic Peripheral neuropathy market has significant unmet need for rational, mechanism-based drugs. ...

New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin

... The Myositis Association, National Patient Advocate Foundation, The neuropathy Association, neuropathy Action Foundation, Patient Services Inc., and Platelet Disorder Support ...

The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future

... peripheral neuropathy. Conditions associated with diabetic peripheral neuropathy include numbness, skin ulcers, constant pain or extreme sensitivity to ... an effective, easy to administer, safe treatment for diabetic peripheral neuropathy with little to no side effects. To date there is no fully effective ...

Diabetics with previous foot ulcers may be able to participate in walking program

... and thus prevent other life threatening illnesses. Diabetic Peripheral neuropathy is a nerve disorder that mostly affects the legs and feet by causing ... less active than most of the population and those with diabetic peripheral neuropathy tend to be even less active." In the MU study, LeMaster examined the ...

The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007

... peripheral neuropathy. Conditions associated with diabetic peripheral neuropathy include numbness, skin ulcers, constant pain or extreme sensitivity to ... pharmaceutical activities that occurred during 2007: Diabetic Peripheral neuropathy - QR-333: The number of enrolled subjects continue to increase in our ...

Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75

... is prescribed in combination with other anti-myeloma therapies. Peripheral neuropathy is a potentially severe, adverse effect of treatment with Thalidomide that ... not be used in patients with clinical signs or symptoms of peripheral neuropathy unless the clinical benefits outweigh the risks. Symptoms may occur some ...

Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy

... in NP-1 against placebo in patients suffering from diabetic peripheral neuropathy (DPN), the most common form of neuropathic pain. Only two medications ... underway. -- A Phase III trial in chemotherapy-induced peripheral neuropathy (CPN) is being conducted by the National Cancer Institute (NCI)-funded ...

EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results

... are underway. Two Phase IIb trials are ongoing, one in diabetic peripheral neuropathy and the second in peripheral herpetic neuropathy. Top-line results from the trial in diabetic neuropathy are expected late this year or early in 2008. Patient dosing has begun in ...

ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment

... ) "Our ReBuilder for Diabetic Peripheral neuropathy has been a steady winner for us. Today we celebrate our 50,000th shipment. ... used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side ...